Lower-income countries rarely gain timely access to FDA-approved drugs tested in their populations, highlighting major global and ethical disparities. Physical access was defined as where a tested ...
This is read by an automated voice. Please report any issues or inconsistencies here. A rare-disease patient questions what drives research costs behind $41,000-per-month medication, even before FDA ...
Missouri, Kansas and Idaho have renewed their efforts to restrict access to the abortion drug mifepristone, filing a joint amended lawsuit against the Food and Drug Administration (FDA). The lawsuit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback